Background: Optimal delivery of regular benzathine penicillin G (BPG) injections prescribed as secondary prophylaxis for acute rheumatic fever (ARF) and rheumatic heart disease (RHD) is vital to preventing disease morbidity and cardiac sequelae in affected pediatric and young adult populations. However, poor uptake of secondary prophylaxis remains a significant challenge to ARF/RHD control programs.
INTRODUCTION
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are a cause of significant morbidity and cardiac mortality amongst pediatric and young adult populations in developing countries, migrants from these nations and minority populations in developed countries [1] . The annual worldwide incidence of ARF has been estimated at over 471 000, [2] with major and minor clinical manifestations including carditis, arthritis, chorea, erythema marginatum, subcutaneous nodules, arthralgia and fever [3] . RHD resulting from recurrent episodes of ARF has an estimated prevalence of at least 15.6 million people globally [2] . An approximate worldwide mortality of 233 000 people per annum [2] is attributed to complications of valvular disease including arrhythmias, heart failure, thromboembolism and infective endocarditis [3] .
Secondary prophylaxis with regular intramuscular injections of benzathine penicillin G (BPG) is a key component of ARF and RHD control programs. This approach aims to prevent group A beta-hemolytic streptococci (GAS) infections and subsequent recurrent episodes of ARF [4] . The World Health Organization (WHO) recommends 3-4 weekly BPG continued for a duration dependent on factors including age, time since the last episode of ARF, risk of streptococcal infections in the area and presence of RHD [4] . According to WHO guidelines, secondary prophylaxis should continue for at least 5 years after the last episode of ARF or until the age of 18 years (whichever is longer) and for a greater length of time in cases of carditis or RHD [4, 5] . However, local health authorities give slightly varying recommendations for the frequency and duration of BPG injections [5] .
Low adherence with secondary prophylaxis is one of the main challenges to effective control of ARF and RHD [4] . To the best of our knowledge, a systematic literature review to summarize what is known regarding rates of adherence and factors associated with adherence to secondary prophylaxis does not exist. This study aims to systematically summarize and evaluate published rates of adherence and factors associated with adherence to BPG injections prescribed as secondary prophylaxis for ARF and RHD, and thereby identify means to improve secondary prophylaxis interventions. In contrast to other studies of adherence in chronic disease management, of particular interest and importance in this review is the focus of adherence amongst poor and underserved population groups.
METHODS

Protocol and Focus
This systematic review has been conducted using the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines [6] . The review focuses on studies that explored rates of adherence and factors associated with adherence to BPG injections recommended as secondary prophylaxis for ARF and RHD worldwide.
Search Criteria
A search of the MEDLINE database via OvidSP was conducted on 28 June 2014. All articles written in the English language between January 1, 1994 and June Week 3, 2014, using the Medical Subject Headings (MeSH) and keywords, ("acute rheumatic fever" OR "rheumatic fever" OR "rheumatic heart disease") AND ("secondary prophylaxis" OR "secondary prevention" OR "benzathine penicillin G" OR "penicillin G benzathine" OR "benzathine penicillin" OR "benzathine benzylpenicillin" OR "disease management" OR "management") AND ("patient compliance" OR "compliance" OR "non-compliance" OR "noncompliance" OR "treatment refusal" OR "guideline adherence" OR "medication adherence" OR "adherence" OR "non-adherence" OR "nonadherence" OR "alignment" OR "non-alignment" OR "nonalignment"), were retrieved. A single investigator (PK) screened the titles and abstracts of all retrieved citations and performed full text reviews of relevant studies. Reference lists of relevant studies were hand searched to identify additional relevant publications.
Eligibility Criteria
Eligibility criteria were determined with expert input from two pediatricians. Primary studies published from January 1, 1994 to June Week 3, 2014, were included in the literature review if they reported rates of adherence to secondary prophylaxis for ARF/RHD or discussed factors associated with adherence to BPG injections recommended as secondary prophylaxis for ARF/RHD. Articles that were not primary studies or were irrelevant to the focus of this review were excluded. This included articles written about the epidemiology and clinical presentation of ARF/RHD, symptomatic treatment of ARF episodes, the efficacy of differing antibiotic regimens prescribed as secondary prophylaxis for ARF/RHD and guidelines for delivery of secondary prophylaxis for ARF/RHD, without reference to rates of adherence or factors associated with adherence to secondary prophylaxis for ARF/RHD.
Data Extraction and Quality Assessment
One investigator (PK) used a standardized sheet to extract data from included studies. Data extracted included the author, year of publication, source, location of study, study design and study population characteristics. Study findings addressing rates of adherence to secondary prophylaxis for ARF/RHD and factors associated with adherence to secondary prophylaxis for ARF/RHD were also summarized.
We created a quality assessment tool to evaluate the methodological quality of included studies incorporating validated elements of Pluye et al. ' s Mixed Methods Assessment Tool (MMAT) [7] and Wells et al.'s checklists for nonrandomized studies in systematic reviews [8] . Our tool assessed methodological quality in ten domains including the incorporation of clear study objectives with suitable data collection, clarity of adherence definition, sample size adequacy, recruitment method, comparability of participant groups, outcome measure rate/response rate, use of inferential statistical analysis, inclusion of multivariate analysis, consideration given to the contextual relation of findings and consideration given to researchers' influence on study findings ( Table 1) .
RESULTS
Search Results and Quality Assessment
Electronic searching retrieved 61 citations from MED-LINE. Based on inclusion and exclusion criteria, 15 of these publications were included in this review (Fig. 1) . Four additional publications identified through reference list searching and one additional publication known to be relevant through prior knowledge were also included in the review. All of the included studies were published in peer-reviewed, scientific journals.
Secondary Prophylaxis Regimens and Definitions of Adherence
Prescribed regimens of BPG varied between health authorities worldwide and included recommendations for 2-weekly, 3-weekly, 4-weekly and monthly BPG. Additionally, there were a number of definitions of "adherence" to secondary prophylaxis employed in the reviewed literature. In some studies, a benchmark percentage or fraction of recommended injections was defined as a case of "adherence", [9, 10] whilst in others, rates of adherence were reported as a percentage of those who received 100% of their prescribed BPG, or a percentage of the total number of recommended injections administered to the study population [11] . Some authors utilized the terms "regular compliance", "irregular compliance" and "non-compliance" as defined by the WHO [12] , whilst others created their own definitions of terms such as "complete compliance", "partial compliance" and "dropout" to describe levels of adherence [13] .
Rates of Adherence
Nineteen publications discussed rates of adherence to secondary prophylaxis; two of these articles utilized the same data set ( Table 2 ). The majority of these were retrospective observational studies, with the exception of one randomized controlled trial measuring outcomes of patients on a 3-weekly versus a 4-weekly regimen [13] , one measure of past adherence by questionnaire [14] , and one assessment of adherence based on qualitative interviews [15] .
Factors Associated with Adherence
Ten of the included studies discussed factors associated with adherence to secondary prophylaxis ( Table 3) . Qualitative, semi-structured interviews were conducted in seven of these studies, two of which additionally included questionnaires. Multivariate logistic regression was performed in one study [9] and other inferential statistical analysis was performed in two studies [18, 19] .
Quality Assessment
Use of the quality assessment tool demonstrated the methodological quality of each of the included studies ( Table 4) .
DISCUSSION
Over the last 20 years, studies addressing adherence to secondary prophylaxis for ARF/RHD have been conducted in India, Egypt, South Africa, Brazil, Cuba, the Northern Mariana Islands, Australia, New Zealand, New Caledonia and Taiwan. On review of this literature, there was a range of adherence to different regimens of BPG prescribed as secondary prophylaxis worldwide. Whilst a small number of studies conducted in Cuba, India and New Zealand reported good overall adherence, adherence measured in the majority of studies was sub-optimal. An individual range of 0-100% of prescribed injections also indicated that despite overall adherence rates, some patients received inadequate BPG injections whilst others received appropriate prophylaxis. Adherence to BPG was not evidently better or worse amongst minority groups and migrants in developed countries compared (188 out of 536) patients 4 Adequate prophylaxis defined as >75% recommended BPG received. 5 Minimum recommended number of doses was 13 injections in 12 months. 6 Total compliance defined as administration of all scheduled injections within predetermined time frames. 7 Regular compliance defined as a minimum of 10-11 BPG injections received per year. 8 Irregular compliance defined as 6-9 BPG injections received per year. 9 Non-compliance defined as ≤5 BPG injections received per year. 10 Patient classified as non-adherent if they missed or delayed >1 dose of BPG during a 6-month period (interval between appointments).
( 11 Patient considered compliant if received at least 11 BPG injections in the last 6 months or 22 BPG injections in the last year. 12 Patient considered not compliant if received <80% of prescribed BPG injections per year. 13 Definition of uncompliant not provided. 14 Compliance defined as percentage of those eligible for secondary prophylaxis who received secondary prophylaxis. 15 Missed no more than 1 BPG injection per year. 16 Complete compliance defined as ≤ 1 BPG injection missed per year. 17 Partial compliance defined as 2-3 BPG injections missed per year. 18 Dropout defined as ≥ 4 BPG injections missed per year. ( Eastern Medi- with adherence in developing countries. Very few studies assessed adherence over time in comparable populations with the same definitions, so global trends regarding this could not be established. In the Cuban study, adherence improved over time from 50% regular compliance in 1986 to >80% regular compliance in 2002, [22] whilst Indian studies demonstrated an adherence decline from 100% compliance in 1988 to 82.4% compliance in 1999 [26, 27] .
Factors Associated with Lower Adherence
In underprivileged settings where ARF and RHD remain prevalent, there are a number of interrelated factors associated with low adherence to secondary prophylaxis. Rurality with limited access to health care was one important theme in four studies, one involving logistic regression analysis (Bassili et al.) and three others including qualitative semistructured interviews. Bassili et al. reported non-adherence to be more common amongst children in semi-urban and rural areas, [24] Mincham et al. found that living in a remote location was a negative influence on adherence [29] and two Indian studies identified lack of local services and long distances of travel as reasons for non-adherence [26, 27] . It follows that for patients living in rural and remote areas with lesser access to health care, adhering to secondary prophylaxis regimens may be more difficult.
Negative patient, staff and health service interactions were also reported as contributors to non-adherence in three studies. Bassili et al.'s logistic regression analysis found non-adherence to be more common among children whose families were not satisfied with the health care provided [24] , and qualitative semi-structured interviews performed by Mincham et al. and Harrington et al. in Australia highlighted that negative patient-staff interactions, limited confidence in the treatment and a lack of sense of "belonging" to the health service could reduce adherence [10, 29] . Mincham et al. and Harrington et al.'s studies also discussed staff factors inhibiting uptake, including the transient nature of staff in remote settings, a negative perception of the secondary prophylaxis program, conflicting health priorities, and no effective strategy for dealing with absent patients leading to staff frustration and fatigue [10, 29] . These findings may be most relevant to Australian Indigenous populations and other minority groups in developed countries, where a difference in cultural values, attitudes and beliefs between the patient/caregiver and health care provider may exist. In Mincham et al.'s study, lack of an effective reminder system for due injections additionally led to non-adherence to secondary prophylaxis [29] .
Other factors associated with non-adherence included lack of family support (observed in two qualitative studies), [10, 27] a disinterest in or conscientious refusal of treatment (discussed in two qualitative studies) [10, 27] and inconvenience of the treatment or treatment interference with personal priorities (identified in two qualitative studies) [10, 29] .
On the field, lack of BPG supply is another known factor leading to lower rates of BPG administration, however this was not raised in the studies reviewed. In prospective studies, this is likely because BPG supply was ensured for the study population. In retrospective observational studies, it may be that supply was assumed to have been adequate by the researchers, and in qualitative interviews and questionnaires perhaps the focus was on individual and health service factors, without consideration of pharmaceutical supply.
Factors Associated with Higher Adherence
Factors associated with higher adherence were also identified in the literature reviewed. Positive patient, staff and health system interactions promoted adherence in three small qualitative studies in Australia and New Zealand. Mincham et al. found that adherence was closely linked with positive patient-staff interactions [29] whilst Harrington et al. identified that patient confidence in the health service and receipt of holistic care, as well as family support for and belief in the treatment, were important to adherence [10] . The presence of appropriately trained, socially and culturally competent staff was discussed by Harrington et al. as a factor associated with higher adherence [10] and supported by Grayson et al.' s report that the presence of community health workers and a rheumatic fever resource nurse impacted positively on adherence [11] . Harrington et al. additionally found that an appropriate location for injections and staff willingness to treat patients at home promoted uptake [10] . These study findings may have greater applicability in countries similar to Australia and New Zealand, where ARF/RHD is most prevalent amongst migrant and minority groups. In Harrington et al.'s study, recall systems for patients with due BPG injections were also associated with higher adherence [10] .
Opportunistic communications may improve adherence to secondary prophylaxis. A qualitative study by Grayson et al. found that communication from other services used by rheumatic fever patients impacted positively on adherence, [11] and Stewart et al.'s retrospective study involving inferential analysis described a non-significant trend towards improved adherence in patients who attended a health clinic more frequently for reasons other than secondary prophylaxis [18] .
Patient demographic factors including younger age and greater number of people per household could also positively influence adherence to secondary prophylaxis. Stewart et al. found a non-significant trend towards improved adherence in patients aged <18 years compared with patients aged ≥18 years amongst those who received ≥50% of prescribed BPG [18] . Perhaps this is because parents/caregivers are overseeing adherence in younger patients; young adults newly responsible for their own health care may have a tendency towards non-adherence. Meanwhile, Gasse et al.'s retrospective study involving multivariate logistic regression analysis identified that a household with ≥6 people was protective against poor adherence. It is postulated that this may be because older siblings in the household are able to assist with health care seeking [9] .
Factors with Unclear Association to Adherence
A number of factors had an unclear association with adherence to secondary prophylaxis. Biomedical knowledge of ARF and RHD was poor amongst patients and their families, yet whilst Bassili et al. described non-adherence to be more common in patients who's parents had only a fair to poor knowledge of the disease, [24] Robertson et al. reported no association between knowledge of the disease and association between knowledge of the disease and adherence [10, 15, 29] . Harrington et al. found that an understanding of the chronic and serious nature of the disease was more relevant than biomedical knowledge [10] . The fact that indicated BPG injections were ceased by patients due to seemingly good health in Kumar et al.'s study also suggests that a level of understanding of the disease course is needed [26] . Certainly, delivering education is thought to be a worthwhile intervention by many and remains an intuitively key aspect of health care [9, 26, 29] . Conflicting results regarding the relationship between patients' parents' level of education and adherence to secondary prophylaxis were also reported, with Bassili et al. describing non-adherence to be more common amongst children whose parents had lower levels of education and occupation [24] and Kumar et al. finding no association between parents' level of education and patients' adherence to secondary prophylaxis [27] .
Certain patient demographic and clinical factors also have an unclear association with secondary prophylaxis adherence. Eissa et al. found that service delivery was better for females than males, [19] however Stewart et al. found that males and females were equally likely to receive monthly BPG [18] . Gasse et al. reported adequate healthcare coverage was protective against poor adherence, [9] yet Bassili et al. described non-adherence as more common in children with health insurance compared to those without [24] . Eissa et al. also found that adherence was higher among patients with moderate or severe disease compared to patients with mild disease [19] . In similar vein, Gasse et al. found that a previous medical history of symptomatic ARF was protective against poor adherence [9] . However, in Stewart et al.'s study patients with more severe disease were less likely to receive monthly BPG [18] .
Pain and dislike of injections as well as the issue of responsibility for injection delivery are other important considerations in adherence. According to one qualitative study, pain associated with injections was not necessarily a deterrent to secondary prophylaxis uptake [10] , however in two qualitative studies, fear/dislike of injections was given as a reason for non-adherence [26, 27] . Harrington et al. and Mincham et al. both commented on the balance of health seeking and health delivery responsibility between patients, caregivers and health staff [10, 29] . A common understanding of roles and responsibilities in a given community appears important to ensuring BPG administration occurs [10, 29] . This balance may differ in urban compared to rural settings, especially in Australia where historically a more paternalistic approach to rural Indigenous health care delivery has been taken [10] . Adherence to secondary prophylaxis for ARF and RHD is evidently a complex and multi-factorial issue.
Strengths and Weaknesses
To the best of our knowledge, this is the first systematic review exploring rates of adherence and factors associated with adherence to secondary prophylaxis for ARF and RHD. Our review was conducted using PRISMA guidelines to ensure a transparent and complete reporting system. However, formal data synthesis with meta-analysis was unable to be performed as authors used different study designs and definitions of adherence, and there were differing regimens for secondary prophylaxis recommended worldwide. Despite this limitation, our use of a modified validated tool for methodological quality assessment allows for the appraisal of included studies.
When examining factors associated with adherence to secondary prophylaxis, it should be taken into consideration that the number of studies from different geographical regions is not proportional to the prevalence of ARF and RHD in those regions. There were six studies from Oceania (four conducted in Australia), two from India, one from Egypt and one from South Africa, whereas India has the highest prevalence of ARF/RHD among these locations. Care must be taken when interpreting and applying review findings within a local context. However, an overlap in factors pertinent to adherence in the different study regions, such as the effect of rurality and access to health services, suggests that some findings may be universally relevant.
What is the Current Knowledge Gap?
Knowledge of rates of adherence to secondary prophylaxis for ARF and RHD promotes an accurate appreciation of the problem of poor uptake. Further studies reporting rates of adherence worldwide are hence warranted, as these data are not available in many countries and may be outdated in others.
Future research may also further explore factors associated with adherence to BPG injections given the limited number of studies addressing this worldwide and global variation in population sociocultural demographics. An understanding of factors associated with adherence can be used by doctors, nurses, community health workers and policy makers to improve service delivery. Patient self-awareness of these factors may also assist in overcoming barriers to receiving secondary prophylaxis.
Can the Situation be Improved?
Interventions to improve adherence to secondary prophylaxis that could be adopted by established ARF/RHD control programs include ensuring an effective active recall system [9, 23] , involving community health workers [30] and delivering education about the disease and its management [9] . It is commonly said, "What gets measured gets managed". Thus, it may be worthwhile to record reasons for failure of patients to attend for BPG injections. This could be made part of a specific protocol for when secondary prophylaxis is missed, with individual follow-up and troubleshooting by a community health worker who has knowledge of local sociocultural and geographic influences. Facilitating a holistic approach in service delivery so that patients and their families feel supported and confident in the care received is vital [10, 24, 27] . It should be noted that these interventions can only be achieved with adequate and sustained financial support and staff resources [19] .
CONCLUSION
Current literature provides some insight into levels of adherence and factors associated with adherence to secondary prophylaxis for ARF and RHD. However, further stud-ies are warranted to develop a better understanding of current adherence rates and factors associated with adherence worldwide. Improved delivery of secondary prophylaxis is necessary to ensure best health outcomes for affected pediatric and young adult populations. Interventions to achieve this should target patient demographic, clinical, sociocultural and health service delivery factors with known association to adherence, and may include implementation of an active recall system, provision of holistic care, involvement of community health workers and delivery of ARF/RHD health education.
